Atai Life Sciences Long Term Debt 2020-2025 | ATAI
Atai Life Sciences long term debt from 2020 to 2025. Long term debt can be defined as the sum of all long term debt fields.
| Atai Life Sciences Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2024 | $15 |
| 2023 | $19 |
| 2022 | $15 |
| 2021 | $1 |
| 2020 | $2 |
| 2019 | $0 |
| Atai Life Sciences Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2025-03-31 | $12 |
| 2024-12-31 | $15 |
| 2024-09-30 | $21 |
| 2024-06-30 | $19 |
| 2024-03-31 | $21 |
| 2023-12-31 | $19 |
| 2023-09-30 | $16 |
| 2023-06-30 | $16 |
| 2023-03-31 | $16 |
| 2022-12-31 | $15 |
| 2022-09-30 | $15 |
| 2022-06-30 | $1 |
| 2022-03-31 | $2 |
| 2021-12-31 | $1 |
| 2021-09-30 | $1 |
| 2021-06-30 | $1 |
| 2021-03-31 | $2 |
| 2020-12-31 | $2 |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.497B | $0.000B |
| atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quest Diagnostics (DGX) | United States | $19.386B | 19.10 |
| Encompass Health (EHC) | United States | $12.226B | 25.92 |
| DaVita (DVA) | United States | $10.399B | 14.62 |
| Chemed (CHE) | United States | $8.204B | 25.78 |
| Elanco Animal Health (ELAN) | United States | $6.670B | 14.29 |
| Option Care Health (OPCH) | United States | $5.268B | 23.48 |
| RadNet (RDNT) | United States | $4.357B | 276.52 |
| Amedisys (AMED) | United States | $3.081B | 20.72 |
| LifeStance Health (LFST) | United States | $2.306B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.064B | 22.66 |
| Astrana Health (ASTH) | United States | $1.390B | 34.44 |
| U.S Physical Therapy (USPH) | United States | $1.152B | 29.73 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.075B | 61.22 |
| Pennant (PNTG) | United States | $1.022B | 37.52 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.047B | 0.00 |
| Daxor (DXR) | United States | $0.043B | 0.00 |
| Ontrak (OTRK) | United States | $0.006B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |